Patent ID: 11890335
Assignee: YALE UNIVERSITY
Field: Pharmaceuticals (Chemistry)
Classification: CPC A  C  Y | IPC A

Claim 11:
12. The pharmaceutical composition of claim 1, wherein the adjuvant comprises at least one immunomodulatory agent selected from the group consisting of complete Freunds adjuvant (CFA), incomplete Freunds adjuvant (IFA), LTK63, dimethyl dioctadecyl-ammonium bromide (DDA), lipophilic quaternary ammonium salt-DDA, Trehalose dimycolate and synthetic derivatives, DDA-MPL, DDA-TDM, DDA-TDB, IC-31, aluminum salts, aluminum hydroxyide, aluminum phosphate, potassium aluminum phosphate, water-in-oil emulsion, mannide monooleate, vegetable grade (VG) oleic acid, ISA-51 VG, ISA-720, microparticles, immuno stimulatory complexes, liposomes, virosomes, virus-like particles, cholera toxin, heat-labile toxin from E. coli, lipoproteins, dendritic cells, IL-12, GM-CSF, nanoparticles, a nanoemulsion of soybean oil and emulsifying agents and ethanol, AS04, Thymalfasin, and combinations of any thereof.